Stock Earnings

Question 1

What are Regeneron Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Regeneron Pharmaceuticals Inc has a total asset of $37,759, Net profit of $4,412

Question 2

What are the key financial ratios for REGN?

Accepted Answer

Regeneron Pharmaceuticals Inc's Current ratio is 4.49, has a Net margin is 31.06, sales per share of $123.38.

Question 3

How is Regeneron Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Regeneron Pharmaceuticals Inc data is not available.

Question 4

Is Regeneron Pharmaceuticals Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Regeneron Pharmaceuticals Inc has a net profit of $4,412

Question 5

Does Regeneron Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Regeneron Pharmaceuticals Inc has liability of 8,405

Question 6

How many outstanding shares for Regeneron Pharmaceuticals Inc?

Accepted Answer

Regeneron Pharmaceuticals Inc has a total outstanding shares of 109.6

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	14,247	14,202	13,117	12,172	16,071	8,497
Revenue Growth (YoY)	3%	8%	8%	-24%	89%	8%
Cost of Revenue	1,955	1,844	1,713	1,301	2,205	1,119
Gross Profit	12,292	12,357	11,403	10,871	13,865	7,377
Selling, General & Admin	3,196	2,954	2,631	2,115	1,824	1,441
Research & Development	5,156	5,132	4,439	3,592	2,864	2,650
Operating Expenses	8,358	8,139	7,068	5,618	4,643	3,810
Other Non Operating Income (Expenses)	38	15	-20	219	50	94
Pretax Income	5,145	4,779	4,199	4,858	9,325	3,810
Income Tax Expense	567	367	245	520	1,250	297
Net Income	4,578	4,412	3,953	4,338	8,075	3,513
Net Income Growth	-2%	12%	-9%	-46%	130%	66%
Shares Outstanding (Diluted)	107.2	115.1	113.7	113.5	112.2	115.1
Shares Change (YoY)	-8%	1%	0%	1%	-3%	0%
EPS (Diluted)	42.7	38.34	34.77	38.22	71.97	30.52
EPS Growth	7%	10%	-9%	-47%	136%	65%
Free Cash Flow	3,881	3,538	3,667	3,398	6,529	2,003
Free Cash Flow Per Share	36.2	30.73	32.25	29.93	58.19	17.4
Gross Margin	86.27%	87%	86.93%	89.31%	86.27%	86.81%
Operating Margin	27.6%	29.7%	33.04%	43.14%	57.38%	41.96%
Profit Margin	32.13%	31.06%	30.13%	35.63%	50.24%	41.34%
Free Cash Flow Margin	27.24%	24.91%	27.95%	27.91%	40.62%	23.57%
EBITDA	4,458	4,700	4,756	5,593	9,508	3,801
EBITDA Margin	31.29%	33.09%	36.25%	45.94%	59.16%	44.73%
D&A For EBITDA	525	482	421	341	286	235
EBIT	3,933	4,218	4,335	5,252	9,222	3,566
EBIT Margin	27.6%	29.7%	33.04%	43.14%	57.38%	41.96%
Effective Tax Rate	11.02%	7.67%	5.83%	10.7%	13.4%	7.79%

Regeneron Pharmaceuticals Inc (REGN) Price